Stay updated on CD101 vs Caspofungin in Candidemia Clinical Trial
Sign up to get notified when there's something new on the CD101 vs Caspofungin in Candidemia Clinical Trial page.

Latest updates to the CD101 vs Caspofungin in Candidemia Clinical Trial page
- Check3 days agoChange DetectedA banner announces that NIH is transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check10 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check17 days agoChange DetectedThe footer now identifies the site revision as v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check31 days agoChange DetectedThe 403 Forbidden error markup and the associated Home link were removed from the page, removing the error-state content and its navigation element.SummaryDifference0.5%

- Check38 days agoChange DetectedThe page now presents a 403 Forbidden error, making the study record inaccessible. The previous content is replaced by an error page.SummaryDifference19%

- Check59 days agoChange DetectedAdded NIH grant/contract attribution for 2015 and updated the page revision to v3.6.6, while the previous v3.6.5 entry was removed. These updates reflect metadata changes rather than study data or results.SummaryDifference0.1%

Stay in the know with updates to CD101 vs Caspofungin in Candidemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD101 vs Caspofungin in Candidemia Clinical Trial page.